Virginia Morello

Virginia Morello has extensive work experience in the field of biotechnology. Virginia started their career in 2007 as a PhD student at the Molecular Biotechnology Center, Torino, where they worked until December 2010. Following their PhD, they joined the Università degli Studi di Torino as a Post Doc in January 2011 and remained there until November 2019. During their time at the university, they also founded EuremAb Srl in 2016. Virginia Morello then worked as a Scientist and Project Manager, as well as a Founder, at AgomAb Therapeutics starting in 2017. In 2019, they transitioned to the role of Senior Scientist at Agomab Therapeutics. Their most recent position is Senior Scientist at Agomab Therapeutics.

Virginia Morello earned a Bachelor's degree in Biotechnology from Università degli Studi di Torino in 2004. Virginia then pursued a Master's degree in Molecular Biotechnology from the same university, graduating in 2006.